INDIVUMED - because every patient is unique

CompanyManagement Team

Prof. Dr. Hartmut Juhl

Founder and Chief Executive Officer

Hartmut Juhl attended medical school at Hamburg University, Germany and afterwards worked for 12 years in surgical oncology and cancer research. In 1998 he moved to Washington, DC (USA) and became Associate Professor for Oncology and Surgery at Georgetown University.  Realizing the urgent need for high-quality biobanks and better resources to develop individualized therapies in cancer, Hartmut Juhl founded INDIVUMED in 2002.

Kevin Sullivan

VP Global Sales

Kevin Sullivan graduated with a degree in chemistry from the University of Maryland, College Park and began his career in the business of the life sciences soon thereafter. After several years in positions of increasing responsibility covering international markets, he spent 12 years in start-up companies building sales and marketing functions before joining INDIVUMED in 2005 as Sales Director of the USA. He became VP Global Sales in 2014.

PD Dr. Kerstin David

VP Research and Services

Kerstin David earned her Ph.D. in Biochemistry from the University of Hamburg, Germany. She has spent all her scientific career working on various aspects of cancer with special focus on proteomics, signal transduction, and apoptosis. Kerstin David joined INDIVUMED in 2002 and heads Reserach and Services.

Dr. Heinz Joachim List

VP Global Key Accounts

Heinz Joachim List received his Ph.D. in Chemistry from the Technical University of Darmstadt, Germany. He has dedicated his entire scientific career to cancer research. In 2002, Heinz Joachim List earned a Master of Business Administration (MBA) degree from Johns Hopkins University in Baltimore, MD, USA. He is responsible for global Key Account Management.

Gudrun Niewel

VP Finance & Controlling

Gudrun Niewel earned her master’s degree in Business from Münster University in 1986. She worked in several controlling and management positions in various industry segments. Gudrun Niewel joined INDIVUMED in November 2008 is responsible for Finance and Controlling.